Journal
/
Cancer Research
/
Injection intracardiaque de cellules cancéreusesde la prostate humaine pour créer un modèle murin de xénogreffe de métastases osseuses…
JoVE Journal
Cancer Research
Cancer Research
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Injection intracardiaque de cellules cancéreuses de la prostate humaine pour créer un modèle murin de xénogreffe de métastases osseuses
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/64589-v
•
06:32 min
•
November 4th, 2022
Injection intracardiaque de cellules cancéreuses de la prostate humaine pour créer un modèle murin de xénogreffe de métastases osseuses
November 4th, 2022
•
Junli Chang*1,2, Xingyuan Sun*1,2, Xiaoping Ma1,2, Peng Zhao1,2, Binhao Shi1,2, Yongjun Wang1,2, Xianghui Han1,3, Yanping Yang1,2
1Longhua Hospital, Shanghai University of Traditional Chinese Medicine, 2Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education, 3Institute of Chinese Traditional Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine
* These authors contributed equally
Chapters
Summary
Please note that all translations are automatically generated.
Click here for the English version.
Ici, nous présentons un protocole pour l’injection intra-cardiaque de cellules cancéreuses de la prostate humaine afin de générer un modèle murin avec des lésions de métastases osseuses.